Table 103-0404 123
Cancer incidence, by selected sites of cancer and sex, three-year average, Canada, provinces, territories and health regions (2011 boundaries), *Archived*
occasional (age-standardized rate per 100,000 population)

Archived Content

Archived information is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.



Data table

The data below is a part of CANSIM table  103-0404.  Use the  Add/Remove data  tab to customize your table.

Selected items [Add/Remove data]
Characteristics 1617181920 = Cancer incidence
by Geography; by Sex; by Selected sites of cancer (ICD-O-3); Characteristics= Cancer incidence
Cancer incidence, by selected sites of cancer and sex, three-year average, Canada, provinces, territories and health regions (2011 boundaries), occasional (age-standardized rate per 100,000 population)
Geography 45 Sex Selected sites of cancer (ICD-O-3) 2001-2003 2002-2004 2003-2005 2004-2006 2005-2007
footnotes
Canada [0] Both sexes All invasive primary cancer sites (including in situ bladder) 13 402.3 400.6 401.2 403.6 404.9
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 50.9 50.6 50.4 50.2 49.9
Bronchus and lung cancer [C34.0-C34.9] 57.9 57.5 57.4 57.3 56.9
Males All invasive primary cancer sites (including in situ bladder) 13 470.3 465.2 464.7 465.5 464.6
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 62.0 61.5 61.1 61.1 60.8
Bronchus and lung cancer [C34.0-C34.9] 74.6 73.0 71.9 70.8 69.3
Prostate cancer [C61.9] 15 125.7 122.2 121.7 123.6 124.3
Females All invasive primary cancer sites (including in situ bladder) 13 354.2 354.7 355.5 358.7 361.3
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 41.9 41.6 41.4 41.1 40.8
Bronchus and lung cancer [C34.0-C34.9] 45.5 45.9 46.5 47.3 47.6
Female breast cancer [C50.0-C50.9] 14 99.8 98.8 97.5 98.0 98.4
Newfoundland and Labrador [10] Both sexes All invasive primary cancer sites (including in situ bladder) 13 358.8 353.4 355.9 368.2 382.6
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 64.2 65.8 68.4 67.7 68.7
Bronchus and lung cancer [C34.0-C34.9] 43.2 42.3 44.3 47.4 49.7
Males All invasive primary cancer sites (including in situ bladder) 13 424.3 412.1 410.7 433.4 450.7
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 77.7 80.4 83.7 84.1 84.7
Bronchus and lung cancer [C34.0-C34.9] 61.7 59.6 60.3 61.7 63.0
Prostate cancer [C61.9] 15 114.7 99.9 93.3 107.1 120.3
Females All invasive primary cancer sites (including in situ bladder) 13 305.4 305.9 312.7 315.3 327.0
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 52.7 53.5 55.5 54.0 55.2
Bronchus and lung cancer [C34.0-C34.9] 27.5 27.3 30.5 35.1 38.4
Female breast cancer [C50.0-C50.9] 14 91.6 88.0 88.9 86.8 85.8
Prince Edward Island [11] Both sexes All invasive primary cancer sites (including in situ bladder) 13 448.6 451.1 452.2 437.3 445.3
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 58.3 61.1 59.9 58.2 54.7
Bronchus and lung cancer [C34.0-C34.9] 60.2 61.1 64.7 64.0 62.5
Males All invasive primary cancer sites (including in situ bladder) 13 541.8 551.7 547.6 540.1 546.9
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 64.3 70.3 68.3 63.3 63.8
Bronchus and lung cancer [C34.0-C34.9] 80.9 79.4 81.3 76.5 73.6
Prostate cancer [C61.9] 15 187.5 177.1 160.8 156.7 165.8
Females All invasive primary cancer sites (including in situ bladder) 13 377.8 374.1 376.1 352.8 361.3
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 54.2 53.2 52.2 53.5 47.4
Bronchus and lung cancer [C34.0-C34.9] 44.9 49.4 52.8 55.4 54.1
Female breast cancer [C50.0-C50.9] 14 102.6 108.4 105.3 91.2 83.9
Nova Scotia by Zone [12] Both sexes All invasive primary cancer sites (including in situ bladder) 13 442.1 439.7 440.0 453.0 456.3
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 61.7 61.2 60.3 60.4 60.7
Bronchus and lung cancer [C34.0-C34.9] 68.5 67.1 67.4 68.0 68.8
Males All invasive primary cancer sites (including in situ bladder) 13 531.0 528.2 528.3 540.8 539.3
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 76.4 76.0 74.2 72.0 72.7
Bronchus and lung cancer [C34.0-C34.9] 89.9 89.2 87.4 86.6 85.0
Prostate cancer [C61.9] 15 136.0 131.3 134.4 144.2 148.3
Females All invasive primary cancer sites (including in situ bladder) 13 376.5 373.0 372.3 385.5 391.9
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 49.9 49.2 49.0 50.9 51.0
Bronchus and lung cancer [C34.0-C34.9] 52.5 50.3 52.1 54.0 56.9
Female breast cancer [C50.0-C50.9] 14 99.8 98.4 96.6 102.1 101.9
New Brunswick [13] Both sexes All invasive primary cancer sites (including in situ bladder) 13 413.9 410.1 420.1 431.5 442.6
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 51.7 49.7 49.7 49.2 50.5
Bronchus and lung cancer [C34.0-C34.9] 68.3 68.0 68.2 69.4 69.6
Males All invasive primary cancer sites (including in situ bladder) 13 497.3 492.1 508.3 521.4 532.9
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 61.2 59.0 60.7 61.9 64.2
Bronchus and lung cancer [C34.0-C34.9] 94.4 92.6 90.4 87.2 87.9
Prostate cancer [C61.9] 15 130.0 129.6 136.9 149.6 158.6
Females All invasive primary cancer sites (including in situ bladder) 13 353.6 350.4 355.0 363.4 371.7
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 43.8 41.7 40.7 38.8 39.3
Bronchus and lung cancer [C34.0-C34.9] 48.7 49.7 51.9 56.5 56.0
Female breast cancer [C50.0-C50.9] 14 97.5 93.8 94.7 92.8 96.3
Quebec [24] 6 Both sexes All invasive primary cancer sites (including in situ bladder) 13 417.6 416.8 418.4 417.5 413.4
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 55.0 54.8 54.1 53.3 52.4
Bronchus and lung cancer [C34.0-C34.9] 73.4 73.1 72.5 71.8 70.1
Males All invasive primary cancer sites (including in situ bladder) 13 499.2 496.1 494.6 489.0 477.6
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 68.9 68.0 66.5 65.7 64.9
Bronchus and lung cancer [C34.0-C34.9] 103.6 100.8 98.5 96.1 91.9
Prostate cancer [C61.9] 15 100.0 101.2 102.5 100.3 96.5
Females All invasive primary cancer sites (including in situ bladder) 13 366.4 366.2 369.5 371.2 371.7
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 44.3 44.4 44.3 43.4 42.4
Bronchus and lung cancer [C34.0-C34.9] 52.6 53.8 54.2 54.6 54.6
Female breast cancer [C50.0-C50.9] 14 103.2 101.3 100.2 100.5 100.6
Ontario by Local Health Integration Network [35] 78 Both sexes All invasive primary cancer sites (including in situ bladder) 13 385.3 386.3 392.0 395.5 398.8
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 48.4 47.8 47.9 48.1 47.8
Bronchus and lung cancer [C34.0-C34.9] 49.4 48.7 49.4 49.5 49.2
Males All invasive primary cancer sites (including in situ bladder) 13 444.1 441.8 448.7 452.1 454.7
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 58.4 57.5 57.6 58.2 57.9
Bronchus and lung cancer [C34.0-C34.9] 61.9 60.3 60.4 59.8 58.8
Prostate cancer [C61.9] 15 128.8 126.2 128.7 133.5 135.7
Females All invasive primary cancer sites (including in situ bladder) 13 343.7 346.9 351.2 354.5 358.0
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 40.1 39.7 39.8 39.5 39.2
Bronchus and lung cancer [C34.0-C34.9] 39.8 39.9 41.2 41.8 42.1
Female breast cancer [C50.0-C50.9] 14 97.6 96.8 96.2 96.9 97.8
Ontario by Health Unit [35] 78 Both sexes All invasive primary cancer sites (including in situ bladder) 13 385.3 386.3 392.0 395.5 398.8
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 48.4 47.8 47.9 48.1 47.8
Bronchus and lung cancer [C34.0-C34.9] 49.4 48.7 49.4 49.5 49.2
Males All invasive primary cancer sites (including in situ bladder) 13 444.1 441.8 448.7 452.1 454.7
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 58.4 57.5 57.6 58.2 57.9
Bronchus and lung cancer [C34.0-C34.9] 61.9 60.3 60.4 59.8 58.8
Prostate cancer [C61.9] 15 128.8 126.2 128.7 133.5 135.7
Females All invasive primary cancer sites (including in situ bladder) 13 343.7 346.9 351.2 354.5 358.0
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 40.1 39.7 39.8 39.5 39.2
Bronchus and lung cancer [C34.0-C34.9] 39.8 39.9 41.2 41.8 42.1
Female breast cancer [C50.0-C50.9] 14 97.6 96.8 96.2 96.9 97.8
Manitoba [46] 9 Both sexes All invasive primary cancer sites (including in situ bladder) 13 411.8 405.4 394.8 390.6 389.7
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 53.3 53.1 50.0 49.9 50.6
Bronchus and lung cancer [C34.0-C34.9] 60.4 59.8 59.0 56.9 56.0
Males All invasive primary cancer sites (including in situ bladder) 13 472.9 466.1 450.3 441.5 440.8
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 65.4 64.7 61.5 60.9 61.7
Bronchus and lung cancer [C34.0-C34.9] 69.5 69.5 69.2 67.2 66.8
Prostate cancer [C61.9] 15 124.8 118.3 107.8 104.5 103.1
Females All invasive primary cancer sites (including in situ bladder) 13 370.7 364.2 357.0 356.4 354.6
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 43.5 43.5 40.5 40.6 41.3
Bronchus and lung cancer [C34.0-C34.9] 54.3 52.9 51.4 49.4 48.0
Female breast cancer [C50.0-C50.9] 14 102.5 101.1 98.1 97.0 96.9
Saskatchewan [47] 9 Both sexes All invasive primary cancer sites (including in situ bladder) 13 403.0 403.0 401.4 397.7 396.8
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 51.0 52.0 52.6 50.7 50.2
Bronchus and lung cancer [C34.0-C34.9] 52.2 51.9 52.5 53.4 54.1
Males All invasive primary cancer sites (including in situ bladder) 13 479.1 482.1 481.7 469.6 458.4
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 62.1 62.9 65.0 62.6 62.3
Bronchus and lung cancer [C34.0-C34.9] 64.8 63.5 63.5 62.2 62.1
Prostate cancer [C61.9] 15 149.4 155.7 157.4 150.0 143.1
Females All invasive primary cancer sites (including in situ bladder) 13 345.3 341.3 338.0 341.2 348.5
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 41.3 42.4 41.7 40.6 39.6
Bronchus and lung cancer [C34.0-C34.9] 43.1 43.5 44.4 47.0 48.5
Female breast cancer [C50.0-C50.9] 14 97.6 95.8 94.8 95.9 97.1
Alberta [48] Both sexes All invasive primary cancer sites (including in situ bladder) 13 417.0 412.9 405.2 399.7 394.8
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 46.8 46.9 47.1 46.6 46.1
Bronchus and lung cancer [C34.0-C34.9] 52.1 52.3 51.9 51.3 50.9
Males All invasive primary cancer sites (including in situ bladder) 13 490.3 478.9 468.9 458.9 451.2
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 58.1 58.1 57.5 57.0 55.7
Bronchus and lung cancer [C34.0-C34.9] 63.3 62.6 61.1 59.5 58.8
Prostate cancer [C61.9] 15 162.6 149.3 140.6 133.4 128.1
Females All invasive primary cancer sites (including in situ bladder) 13 360.9 363.0 356.3 354.3 351.8
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 37.4 37.5 38.1 37.6 37.5
Bronchus and lung cancer [C34.0-C34.9] 43.6 44.6 45.0 45.3 45.1
Female breast cancer [C50.0-C50.9] 14 103.5 103.9 98.7 97.0 95.6
British Columbia [59] Both sexes All invasive primary cancer sites (including in situ bladder) 13 364.4 361.4 360.5 361.0 367.9
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 43.4 43.8 44.3 44.4 44.2
Bronchus and lung cancer [C34.0-C34.9] 48.2 49.3 49.4 48.7 48.8
Males All invasive primary cancer sites (including in situ bladder) 13 421.9 412.9 409.9 409.7 420.5
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 51.5 52.2 53.1 53.0 53.0
Bronchus and lung cancer [C34.0-C34.9] 56.5 57.0 56.7 55.1 54.9
Prostate cancer [C61.9] 15 120.7 113.5 108.9 112.2 119.9
Females All invasive primary cancer sites (including in situ bladder) 13 319.4 321.0 321.6 322.4 325.5
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 36.4 36.7 36.6 36.8 36.4
Bronchus and lung cancer [C34.0-C34.9] 42.0 43.7 43.9 43.9 44.2
Female breast cancer [C50.0-C50.9] 14 90.8 90.8 91.5 92.0 92.9
Yukon [60] Both sexes All invasive primary cancer sites (including in situ bladder) 13 391.7 411.2 392.9 377.4 355.5
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 56.1 55.5 56.4 60.8 50.6
Bronchus and lung cancer [C34.0-C34.9] 62.7 67.9 60.8 54.5 49.6
Males All invasive primary cancer sites (including in situ bladder) 13 439.2 468.6 439.2 399.1 362.9
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 51.0 63.4 61.0 72.3 54.6
Bronchus and lung cancer [C34.0-C34.9] 81.9 79.3 77.5 62.7 60.4
Prostate cancer [C61.9] 15 110.1 108.1 121.8 94.6 94.8
Females All invasive primary cancer sites (including in situ bladder) 13 343.5 353.8 344.2 350.2 341.9
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 58.1 43.6 47.6 44.9 42.2
Bronchus and lung cancer [C34.0-C34.9] 39.9 53.8 41.3 45.1 38.0
Female breast cancer [C50.0-C50.9] 14 89.6 104.2 102.5 111.1 94.6
Northwest Territories [61] 12 Both sexes All invasive primary cancer sites (including in situ bladder) 13 410.7 441.0 434.7 389.0 400.0
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 95.5 109.9 83.2 68.5 72.0
Bronchus and lung cancer [C34.0-C34.9] 53.5 69.9 72.7 75.1 72.1
Males All invasive primary cancer sites (including in situ bladder) 13 404.8 464.8 476.3 450.4 450.3
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 117.6 155.9 113.5 88.0 76.0
Bronchus and lung cancer [C34.0-C34.9] 45.6 59.8 72.4 87.0 92.8
Prostate cancer [C61.9] 15 84.1 80.4 114.1 111.0 127.8
Females All invasive primary cancer sites (including in situ bladder) 13 433.8 425.2 394.5 323.2 348.5
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 78.4 64.3 52.1 46.6 67.5
Bronchus and lung cancer [C34.0-C34.9] 63.3 83.9 75.8 65.7 52.8
Female breast cancer [C50.0-C50.9] 14 146.7 129.5 120.8 83.8 90.1
Nunavut [62] 12 Both sexes All invasive primary cancer sites (including in situ bladder) 13 636.0 549.7 579.6 511.4 512.1
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 91.5 65.0 108.3 105.3 122.0
Bronchus and lung cancer [C34.0-C34.9] 310.4 273.6 249.7 212.6 206.8
Males All invasive primary cancer sites (including in situ bladder) 13 576.0 536.6 591.8 508.5 517.3
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 61.2 72.1 125.1 117.3 138.7
Bronchus and lung cancer [C34.0-C34.9] 288.1 249.4 255.4 219.4 229.8
Prostate cancer [C61.9] 15 64.7 x x x x
Females All invasive primary cancer sites (including in situ bladder) 13 731.3 574.5 561.1 515.9 502.6
Colon, rectum and rectosigmoid junction cancer [C18.0-C18.9,  C19.9,  C20.9,  C26.0] 136.4 56.8 86.6 93.3 101.2
Bronchus and lung cancer [C34.0-C34.9] 343.9 309.7 236.9 203.0 178.0
Female breast cancer [C50.0-C50.9] 14 23.9 31.7 69.0 87.1 80.2

Symbol legend:

x
Suppressed to meet the confidentiality requirements of the Statistics Act

Footnotes:

Sources: Statistics Canada, Canadian Cancer Registry (CCR) Database (July 2011 file) and Demography Division (population estimates). The CANSIM table 103-0404 has been archived. It was an update of the CANSIM table 103-0403. More recent data are in CANSIM table 103-0406.
World Health Organization, International Classification of Diseases for Oncology, Third Edition (ICD-O-3) and the International Agency for Research on Cancer (IARC) rules for determining multiple primaries sites.
Cancer incidence refers to new primary sites of malignant neoplasms. The Canadian Cancer Registry (CCR) is a dynamic database that can be updated with new records or changes to previous records, therefore, the incidence counts may vary from one release to the next.
Health regions are administrative areas defined by provincial ministries of health according to provincial legislation. The health regions presented in this table are based on boundaries and names in effect as of October 2011. For complete Canadian coverage, each northern territory represents a health region.
Peer groups are aggregations of health regions that share similar socio-economic and demographic characteristics, based on 2006 Census data. These are useful in the analysis of health regions, where important differences may be detected by comparing health regions within a peer group. The ten peer groups are identified by the letters A through J, which are appended to the health region 4-digit code. Caution should be taken when comparing data for the peer groups over time due to changes in the peer groups. For more information on the peer groups classification, consult Statistics Canada's publication "Health Indicators" (catalogue number 82-221-XWE).
To help with results interpretation, it is important to note that cancers reported to the Quebec Tumour Registry are those that required hospitalization or day surgery. Therefore, certain cases diagnosed and treated solely on an external or ambulatory basis are not reported to the Quebec Tumour Registry, or some cases are reported at a more advanced stage of the disease when hospitalization is required. A 2003 comprehensive study estimates, among other things, that more than a third of prostate cancers and melanomas are not reported to the Quebec Tumour Registry because of our reporting source. Overall, 90% of cancer cases confirmed by histopathology are reported to the Quebec Tumour Registry.
In Ontario, Public Health Units (PHU) administer health promotion and disease prevention programs. Local Health Integration Networks (LHIN) are responsible for planning, funding and administering health care programs and services across the province. Data are provided for both PHUs and LHINs. However, since the weights for the Canadian Community Health Survey sample are primarily based on PHUs, only estimates for rates (percentages) are available by LHIN in the profile. Special LHIN weights are available upon request. These weights will allow for more precise estimation at the LHIN level including the estimation of totals.
Ontario does not report in situ bladder cases to the Canadian Cancer Registry. Non-melanoma skin cancers are not registered in Ontario. Incidence for Kaposi's is heavily underestimated.
In Manitoba and Saskatchewan, health regions are referred to as Health Authorities (HA) or Regional Health Authorities (RHA).
To avoid data suppression, northern regions in Manitoba have been grouped with neighbouring regions, as follows: Churchill Regional Health Authority (4690) is combined with Burntwood Regional Health Authority (4680) and referred to as Burntwood/Churchill (4685).
To avoid data suppression, northern regions in Saskatchewan have been grouped with neighbouring regions, as follows: Athabasca Health Authority (4713) is combined with Mamawetan Churchill River Regional Health Authority (4711) and Keewatin Yatthé Regional Health Authority (4712) and referred to as Mamawetan/Keewatin/Athabasca (4714).
Nunavut became a territory in April 1999 and historical data are provided for comparison purposes. Current and historical cancer data are presented for the current boundaries of the Northwest Territories and Nunavut.
Excluding morphology types M-9050 to M-9055; M-9140; M-9590 to M-9989.
Rates for breast cancer (International Classification of Diseases for Oncology, Third Edition (ICD-O-3) codes C50.0 to C50.9) were calculated for females only.
Rates for prostate cancer (International Classification of Diseases for Oncology, Third Edition (ICD-O-3) code C61.9) were calculated for males only.
Cancer incidence rates are age-standardized using the direct method and the 1991 Canadian Census population structure. The use of a standard population results in more meaningful incidence rate comparisons, because it adjusts for variations in population age distributions over time and across geographic areas.
The confidence intervals for the age-standardized cancer incidence rates were produced using the method found in the following reference: Fay M.P. and E.J. Feuer. 1997. "Confidence intervals for directly standardized rates: a method based on the gamma distribution." Statistics in Medicine. Volume 16, pages 791 to 801.
The 95% confidence interval (CI) illustrates the degree of variability associated with a rate. Wide confidence intervals indicate high variability, thus, these rates should be interpreted and compared with due caution.
G-Confid, developed at Statistics Canada, is used to prevent the disclosure of low-incidence cells in cancer data. All non-empty cells based on fewer than five cases (sensitive cells) are suppressed, and additional cells based on five or more cases are suppressed to ensure that sensitive cells' value cannot be calculated from the released table.
The following standard symbols are used in this Statistics Canada table: (..) for figures not available for a specific reference period, (...) for figures not applicable and (x) for figures suppressed to meet the confidentiality requirements of the Statistics Act.
This variable provides direction and statistical significance of the difference between estimates (p < 0.05). A value of +1 means the difference observed is significantly higher, -1 means the difference is significantly lower and 0 means the difference is not statistically significant.

Source:  Statistics Canada. Table  103-0404 -  Cancer incidence, by selected sites of cancer and sex, three-year average, Canada, provinces, territories and health regions (2011 boundaries), occasional (age-standardized rate per 100,000 population),  CANSIM (database). (accessed: )
Back to search

Add/Remove data

Select the specific items from each step to create your customized CANSIM table.

Step 1- Select: Geography 45  

(15 of 162 items selected)
D1-picklist-container

Step 2- Select: Sex  

(3 of 3 items selected)
D2-picklist-container

Step 3- Select: Selected sites of cancer (ICD-O-3)  

(5 of 5 items selected)
D3-picklist-container

Step 4- Select: Characteristics 1617181920  

(1 of 7 items selected)
D4-picklist-container

Step 5 - Select the time frame

By default, only data for the most recent periods available will be retrieved. You may use the lists below to select a different time frame.
From period:  To period: (Occasional data)

Step 6 - Select the Screen output format






Step 7

 

Download

Select an option to download data in the desired format.

Option 1 - Download data as displayed in the Data table tab
 

 

 




Option 2 - Download entire table
(Files modified on 2017-03-09)



Data table will contain:
Note: 
Statistics Canada assumes responsibility for the quality of data as retrieved with the frequency unchanged. Clients take responsibility for any manipulations made to the original data.
Frequency of data is already of annual frequency or greater, therefore no frequency conversion options are presented.
View additional information related to this table.

Related data tables

Related publications
View list of related publications.

Additional information on the survey or statistical program


Help

Data table

When first opening a CANSIM table, the data that is shown is considered the initial view. Depending on the size of the CANSIM table, this table might only represent a summary with five reference periods, if available. You can use the Add/Remove data tab to add or remove data.

To download the entire table, select option 2 in the Download tab.

Add/Remove data

The Add/Remove data tab is a pick list where you choose which subset of the selected table you want to work with. There is one scrollable pick list for each dimension in the table and you must select at least one item from each list before selecting Apply.

An All checkbox appears under each dimension title and just above the scrollable list. Level checkboxes will appear for dimensions containing hierarchies. An Expand/Collapse option is available near the scrollable list which lets you open a dimension to see the list of its members/items.

Before proceeding with the request, check the data ranges for which data is available and reduce this range if you wish; data retrievals are faster when the time period is short. Also, you can select one of four options of a screen output format, default being HTML table, times as column.

Once done with your selections, select Apply to view your customized selection, or select Back to original table to return the selections back to the CANSIM initial view that was shown when first opening the table.

Note: There is no guarantee that data exist for every intersection of every dimension; so it is possible that even if you have selected at least one member/item from all the lists you might still be warned that your retrieval contains no series.

Note: If the designation (Terminated) appears at the end of a member/item name that member/item is terminated. Time series attached to a terminated member/item may be revised, but are no longer updated and may not contain data for the most recent time periods.

Tips for selecting members/items:

  • You can select all members/items in a hierarchical level by selecting the corresponding level.

Note: If you receive an error message after selecting your members from the pick list it's either because your request does not contain series or one member/item has not been selected from a dimension.

Manipulate

Statistics Canada assumes responsibility for the quality of data as retrieved with the frequency unchanged. Clients take responsibility for any manipulations made to the original data.

Frequency of output data will be:

The frequency conversion options are particularly useful to convert data from one frequency to another for comparability purposes.

Note: When frequency of data is already of annual frequency or greater, then no frequency conversion options are presented. Certain series can only be aggregated by specific methods. If the frequency conversion chosen is not allowed, resultant data will appear as "..".

Converted to:

The frequency designates how often data observations are published. A table can contain only one frequency. By default, the frequency of output data will be left unchanged.

Frequency can be converted by these choices:

  • Annual average: Conversion by averaging is more appropriate for "balance"-type data such as "Population as of July 1" as well as rates and indexes.
  • Annual sum: Conversion to a sum should not be performed on a rate or index. Conversion by summing is more appropriate for "count"-type data, such as "Number of cars sold" or "Number of births".
  • Quarterly average: Conversion by averaging is more appropriate for "balance"-type data such as "Population as of July 1" as well as rates and indexes.)
  • Quarterly sum: Conversion by summing is more appropriate for "count"-type data, such as "Number of cars sold" or "Number of births".
  • Annual - convert to annual by selecting a specific month or quarter: This type of calculation is most useful when data for a specific sub-annual period (month or quarter) is used to state an annual figure such as "Population as of July 1".

When converting frequency by summing or averaging:

Two choices are offered when converting frequency using either a sum or an average:

  • Use calendar year: This is a normal calendar year starting in January and ending in December.
  • Use fiscal year ending with last month retrieved: The annual non-calendar fiscal year average manipulation permits users to calculate the average value for the last twelve months ending with the most recent reference period selected. In order to complete this calculation, please follow these steps:
    • In the section entitled "Frequency of output data will be:" sub-section "Standard frequency conversion options" select "Annual (average)".
    • In the section "When converting frequency by summing or averaging:" select "Use fiscal year ending with last month retrieved".
    • If you wish the output of your data as a percentage change from the previous year please select "Percent changes, year-to-year" found below "Data table will contain:"

Data table will contain:

Select one of these data transformations options to convert your data:

  • Percent changes, period-over-period: If the frequency of the data is monthly, the calculation would measure the change of the data value in percent between consecutive time periods, (for example: between July 1998 and August 1998.)
  • Percent changes, year-over-year: If the frequency of the data is monthly, the calculation would measure the change of the data value in percent between consecutive years, (for example: between July 1998 and July 1999).
  • Year-to-date sums: Data for each sub-annual period is added consecutively to the previous period showing cumulative sums for each period.
  • Year-to-date average: Data for each sub-annual period is averaged consecutively to the previous period showing cumulative averages for each period.

Note: CANSIM rounds data using statistician's rounding (also known as round-to-even method, unbiased rounding, convergent rounding and banker's rounding) which may differ from rounding methods used by common spreadsheet software.

Statistician's rounding rounds the following way:

  • If the second decimal is larger than 5, the first decimal is incremented by 1 (see example 1).
  • If the second decimal is smaller than 5, the first decimal stays unchanged (see example 2).
  • When the second decimal is exactly 5, the "odd/even" rules apply. The first decimal is incremented by 1 if it is odd (see example 4), and left unchanged if it is even (see example 3).
  • Example:
    1. 4.46 rounded to one decimal equals 4.5
    2. 4.44 rounded to one decimal equals 4.4
    3. 4.45 rounded to one decimal equals 4.4
    4. 4.15 rounded to one decimal equals 4.2

Once you made your selections select the Apply button.

Download

Option 1 - Download data as displayed in the Data table tab

This option downloads your selection and is displayed in the Data table tab or you can modify using the download options.

Three download options are available:

  • Select the language: You have the choice of the English or French language for the textual content.
  • Select the data output format type: You have the choice of the following six format types:
    • time as columns, where the time frame you have selected will be displayed in columns
    • time as rows, where the time frame you have selected will be displayed in rows.
    • for database loading, where you will download a flat format file ready for database loading
    • for database loading with data quality indicators, where you will download a flat format file including data quality indicators
    • time as columns with data quality indicators, where the time frame you have selected will be displayed in columns including data quality indicators
    • time as rows with data quality indicators, where the time frame you have selected will be displayed in rows including data quality indicators
  • Select the file format: you will have the choice of the following two output separator types:
    • CSV (comma-separated values) English spreadsheet is usually used when retrieving English tables with computers having their Regional set to English.

If your objective is to load the data into a spreadsheet package the best choice for output format is a comma-separated values (CSV) file.

Note: CSV and Semicolon-Separated Values (SCSV) files are produced differently whether you perform the retrieval in English or French. This is because, in French, the comma is used to indicate decimals; a different separator (a semicolon) must therefore be used. SCSV files retrieved in French will parse correctly only if the Regional Settings are set to French.

Once you made your selections select the Download data button.

Option 2 - Download entire table

You will have the option to Download entire table as a CSV file or a Beyond 20/20 or SDMX file which will open a new window.

This table represents all of the items in the CANSIM table. To get an initial view (summary) of the CANSIM table, select the Data table tab.

Note: Downloading tables in Beyond 20/20 output format requires the Beyond 20/20 Table Browser.

Once you made your selections select the Download entire table button.

Related information

This page contains links to items related to your CANSIM table. Select the various links to view these related items.

Related data tables

View a list of related CANSIM tables that are related to this CANSIM table.

Related publications

View the latest article from The Daily and a list of related publications from Statistics Canada.

The Daily is Statistics Canada's official release bulletin, the Agency's first line of communication with the media and the public. The Daily issues news releases on current social and economic conditions and announces new products. It provides a comprehensive one-stop overview of new information available from Statistics Canada.

Additional information on the survey or statistical program

Definitions, data sources and methods: Here is where you will find a link to the Integrated Meta Data Base (IMDB) where you may view details for the survey number(s) assigned to the CANSIM table.

The Integrated Meta Data Base (IMDB) contains information about the surveys and statistical programs carried out by Statistics Canada and other agencies to collect assemble process and disseminate statistical information.

The IMDB may be used to find out how data for particular CANSIM tables are collected or to identify contacts for questions on the data or survey methodology. The IMDB contains descriptions of over 450 surveys and statistical programs each identified by a unique four-digit survey number.

After selecting a survey or a program from the list, you may choose to either retrieve the list of CANSIM tables for that survey or program, or consult the IMDB for more information.